|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 654.27 USD | +4.73% |
|
+5.50% | -15.24% |
| 07-01 | MLCC Prices Surge as AI Supply Chain Faces New Bottleneck |  |
| 06-29 | Eli Lilly, Regeneron Among First Companies in FDA PreCheck Pilot Program | MT |
| Market Cap | 66.56B 58.19B 53.48B 49.85B 94.55B 6,338B 95.98B 642B 250B 3,115B 250B 244B 10,736B | P/E 2026 * |
16.9x | P/E 2027 * | 13.6x |
|---|---|---|---|---|---|
| Enterprise Value | 58.65B 51.27B 47.12B 43.92B 83.31B 5,584B 84.57B 566B 220B 2,745B 220B 215B 9,459B | EV / Sales 2026 * |
3.69x | EV / Sales 2027 * | 3.18x |
| Free-Float |
72.33% | Yield 2026 * |
0.6% | Yield 2027 * | 0.68% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +4.73% | ||
| 1 week | +5.50% | ||
| Current month | +4.93% | ||
| 1 month | +8.52% | ||
| 3 months | -14.12% | ||
| 6 months | -15.72% | ||
| Current year | -15.24% |
| 1 week | 622.29 |  | 654.94 |
| 1 month | 594.9 | | 654.94 |
| Current year | 591.52 | | 821.11 |
| 1 year | 532.6 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 31/12/2000 | |
| Chief Executive Officer | 73 | 07/01/1988 | |
| Director of Finance/CFO | 55 | 04/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 08/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 31/05/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 31/05/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-30 | Sell | Director | -100 | 0.0001% | ||
| 03-31 | Sell | Director | 100 | 0.0001% | ||
| 03-01 | Sell | Director | 100 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.73% | +5.50% | +19.45% | -8.94% | 66.56B | |
| -1.93% | +0.39% | +58.62% | +226.33% | 57.64B | |
| +1.07% | +42.10% | +42.10% | +42.10% | 42.24B | |
| +3.45% | +3.54% | -49.20% | -56.09% | 39.09B | |
| -4.05% | +7.01% | +62.26% | -24.13% | 31.91B | |
| -1.99% | +33.49% | +163.41% | -34.35% | 31.65B | |
| -0.28% | +8.68% | +71.42% | +87.73% | 23.35B | |
| +2.87% | +15.37% | +10.72% | +196.62% | 18.92B | |
| -0.13% | +2.75% | +67.48% | +130.07% | 17.17B | |
| -1.53% | +10.76% | +80.22% | +348.78% | 15.12B | |
| Average | +2.94% | +7.72% | +52.65% | +90.81% | 34.37B | |
| Weighted average by Cap. | +2.81% | +6.68% | +46.35% | +68.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.88B 13.88B 12.76B 11.89B 22.56B 1,512B 22.9B 153B 59.54B 743B 59.61B 58.33B 2,561B | 17.55B 15.34B 14.1B 13.14B 24.93B 1,671B 25.31B 169B 65.81B 822B 65.89B 64.47B 2,831B |
| Net income | 4.09B 3.57B 3.28B 3.06B 5.81B 389B 5.9B 39.43B 15.33B 191B 15.35B 15.02B 659B | 5.13B 4.49B 4.12B 3.84B 7.29B 489B 7.4B 49.51B 19.25B 240B 19.27B 18.85B 828B |
| Net Debt | -7.91B -6.92B -6.36B -5.93B -11.24B -753B -11.41B -76.32B -29.67B -370B -29.7B -29.06B -1,276B | -10.69B -9.34B -8.58B -8B -15.18B -1,017B -15.41B -103B -40.06B -500B -40.11B -39.25B -1,723B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | US$654.27 | +4.73% | 1,071,604 |
| 01/07/26 | US$624.72 | +0.19% | 1,170,657 |
| 30/06/26 | US$623.54 | -1.31% | 820,925 |
| 29/06/26 | US$631.81 | -0.17% | 734,528 |
| 26/06/26 | US$632.90 | +2.06% | 1,213,634 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
